JP2021521142A5 - - Google Patents

Info

Publication number
JP2021521142A5
JP2021521142A5 JP2020555239A JP2020555239A JP2021521142A5 JP 2021521142 A5 JP2021521142 A5 JP 2021521142A5 JP 2020555239 A JP2020555239 A JP 2020555239A JP 2020555239 A JP2020555239 A JP 2020555239A JP 2021521142 A5 JP2021521142 A5 JP 2021521142A5
Authority
JP
Japan
Prior art keywords
methyl
oxo
chloro
cyclohexyl
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020555239A
Other languages
English (en)
Japanese (ja)
Other versions
JP7357932B2 (ja
JP2021521142A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/015392 external-priority patent/WO2019198692A1/en
Publication of JP2021521142A publication Critical patent/JP2021521142A/ja
Publication of JP2021521142A5 publication Critical patent/JP2021521142A5/ja
Application granted granted Critical
Publication of JP7357932B2 publication Critical patent/JP7357932B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020555239A 2018-04-09 2019-04-09 Crhr2拮抗薬としての縮合環状尿素誘導体 Active JP7357932B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862654628P 2018-04-09 2018-04-09
US62/654,628 2018-04-09
PCT/JP2019/015392 WO2019198692A1 (en) 2018-04-09 2019-04-09 Fused cyclic urea derivatives as crhr2 antagonist

Publications (3)

Publication Number Publication Date
JP2021521142A JP2021521142A (ja) 2021-08-26
JP2021521142A5 true JP2021521142A5 (cg-RX-API-DMAC10.html) 2023-05-19
JP7357932B2 JP7357932B2 (ja) 2023-10-10

Family

ID=68164246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020555239A Active JP7357932B2 (ja) 2018-04-09 2019-04-09 Crhr2拮抗薬としての縮合環状尿素誘導体

Country Status (11)

Country Link
US (1) US11802120B2 (cg-RX-API-DMAC10.html)
EP (1) EP3774739B1 (cg-RX-API-DMAC10.html)
JP (1) JP7357932B2 (cg-RX-API-DMAC10.html)
KR (1) KR102590854B1 (cg-RX-API-DMAC10.html)
CN (1) CN111868037B (cg-RX-API-DMAC10.html)
BR (1) BR112020020708A8 (cg-RX-API-DMAC10.html)
CA (1) CA3094609A1 (cg-RX-API-DMAC10.html)
ES (1) ES2917634T3 (cg-RX-API-DMAC10.html)
MX (1) MX2020010568A (cg-RX-API-DMAC10.html)
TW (1) TWI822754B (cg-RX-API-DMAC10.html)
WO (1) WO2019198692A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR122023023802A2 (pt) 2015-04-29 2023-12-26 Janssen Pharmaceutica Nv Compostos azabenzimidazóis, seu uso como moduladores do receptor de ampa e composições farmacêuticas que os compreendem
WO2021145401A1 (en) * 2020-01-15 2021-07-22 Raqualia Pharma Inc. Spiroheterocyclic derivatives as crhr2 antagonist
EP3901152A1 (en) * 2020-04-23 2021-10-27 F. Hoffmann-La Roche AG Kv3 enhancers for the treatment of cognitive disorders
CR20220565A (es) * 2020-05-06 2023-01-13 Merck Sharp & Dohme Llc Inhibidores de il4i1 y métodos de uso
WO2022071484A1 (en) * 2020-09-30 2022-04-07 Raqualia Pharma Inc. 3-hydroxyoxindole derivatives as crhr2 antagonist
WO2022228365A1 (zh) * 2021-04-27 2022-11-03 南京明德新药研发有限公司 六元杂芳并脲环的衍生物及其应用
KR20250113346A (ko) * 2024-01-17 2025-07-25 주식회사 엘지화학 CBP/p300 저해제로 사용되는 신규 화합물, 및 이를 유효성분으로 포함하는 암, 염증성 장애 또는 자가면역 질환의 예방 또는 치료용 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3538899A (en) * 1998-04-30 1999-11-23 Nippon Chemiphar Co. Ltd. Condensed imidazole derivative and therapeutic agent for liver disease
CA2446514A1 (en) 2001-04-30 2002-11-07 Glaxo Group Limited Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
ATE397609T1 (de) * 2001-06-12 2008-06-15 Glaxo Group Ltd Corticotropinfreisetzungsfaktor antagonisten
JP2007161585A (ja) * 2004-06-25 2007-06-28 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
US7652035B2 (en) 2004-10-19 2010-01-26 Neurocrine Bioscience, Inc. CRF receptor antagonists and methods relating thereto
US10166271B2 (en) 2006-06-21 2019-01-01 The Regents Of The University Of California Methods for promoting hair growth
US8273900B2 (en) 2008-08-07 2012-09-25 Novartis Ag Organic compounds
AR080056A1 (es) * 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
JP2015516979A (ja) 2012-04-23 2015-06-18 ホルスボールマッシュマイヤー ニューロケミー ゲーエムベーハーHolsboermaschmeyer Neurochemie Gmbh Crh過剰活性を有する患者の治療に用いるためのcrhr1アンタゴニスト

Similar Documents

Publication Publication Date Title
JP2017530960A5 (cg-RX-API-DMAC10.html)
CN111868037B (zh) 作为crhr2拮抗剂的稠合环状脲衍生物
HRP20200962T1 (hr) Novi spojevi
US8987301B2 (en) Heteroarylaminoquinolines as TGF-beta receptor kinase inhibitors
RU2015129538A (ru) Замещенные имидазопиридины в качестве ингибиторов hdm2
JP5987005B2 (ja) オレキシン拮抗薬として有用な新規なピラゾール及びイミダゾール誘導体
JP2020514267A5 (cg-RX-API-DMAC10.html)
AU2018334290A1 (en) Pyridazinones and methods of use thereof
RU2016140338A (ru) Азаспиро производные в качестве антагонистов trpm8
RU2003107016A (ru) Замещенные пиразолы
CA2570987A1 (en) Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
JP2013519724A5 (cg-RX-API-DMAC10.html)
JP2015514783A (ja) ベンゾチアゾール−6−イル酢酸誘導体およびhiv感染を処置するためのそれらの使用
RU2014119244A (ru) Гетероциклические соединения и способы их использования
US11814384B2 (en) Inhibtors of Raf kinases
US20240109900A1 (en) Azabicyclic shp2 inhibitors
JP2023145748A (ja) 新規トリアゾロン誘導体またはその塩、およびこれらを含む医薬組成物
JP2021519294A5 (cg-RX-API-DMAC10.html)
US12421191B2 (en) 3-hydroxyoxindole derivatives as CRHR2 antagonist
RU2020134947A (ru) Производные конденсированной циклической мочевины в антагонист crhr2
RU2778641C2 (ru) Производные конденсированной циклической мочевины в антагонист crhr2
HK40043109A (en) Fused cyclic urea derivatives as crhr2 antagonist
HK40043109B (en) Fused cyclic urea derivatives as crhr2 antagonist
WO2025259929A1 (en) COMPOUNDS AND COMPOSITIONS AS c-Kit KINASE INHIBITORS
JPWO2024111560A5 (cg-RX-API-DMAC10.html)